Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Viral validation design of a manufacturing process.

¹Texcell Laboratory, Institut Pasteur, Paris, France.

Developments in Biological Standardization

|July 15, 1999

Summary

This study details viral validation methods for biological products, emphasizing process parameter control for effective viral inactivation and elimination. It highlights the importance of identifying and demonstrating each parameter's contribution to viral reduction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[The problem of microbiological risks].

Pathologie-biologie·2000

Same author

Viral inactivation of human bone tissue using supercritical fluid extraction.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·1998

Same author

Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon).

The Journal of general virology·1994

Same author

Comparison of the sensitivity of nested PCR in the 5' non-coding and the NS5 regions of the HCV genome.

Journal of hepatology·1994

Same author

Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their children.

Digestive diseases and sciences·1993

Same author

Chronic non-B, non-C hepatitis among blood donors assessed with HCV third generation tests and polymerase chain reaction.

Journal of hepatology·1993

Area of Science:

Biopharmaceutical Manufacturing
Viral Safety
Process Validation

Background:

Biological product safety relies on viral clearance, not just direct testing.
Manufacturing processes must demonstrate viral inactivation/elimination capabilities.
Viral validation studies face challenges in attributing viral reduction to specific process parameters.

Purpose of the Study:

To outline a systematic approach for viral validation studies.
To identify critical in-process parameters influencing viral reduction.
To ensure robust viral safety evaluation of biological products.

Main Methods:

Voluntary addition of virus load at various process steps.
Evaluation of viral reduction across manufacturing steps.
Parallel control experiments: hold controls, individual parameter controls, and stabilizer-free controls.
Cytotoxicity and interference experiments for in vitro assay validation.
Study of viral inactivation kinetics and parameter-specific effects.

Main Results:

Identification of parameters influencing viral reduction is crucial for study design.
Control experiments validate the contribution of individual parameters.
Viral inactivation kinetics demonstrate progressive viral load decrease.
Demonstration of viral reduction under in-process limits and identification of inactivation phases.

Conclusions:

A comprehensive approach to viral validation requires identifying and controlling all parameters affecting viral reduction.
Demonstrating the contribution of each parameter ensures process robustness.
Thorough validation studies are essential for guaranteeing the viral safety of biological products.

Related Experiment Videos